|
Congressional
Testimony - 2005
 DEC
13, 2005 |
Written
Statement of Joseph T. Rannazzisi Before the United States House
of Representatives Energy & Commerce Committee Subcommittee
on Oversight & Investigations |
| NOV
9, 2005 |
“The
Illicit Drug Transit Zone in Central America” |
| OCT
20, 2005 |
“Comprehensively
Combating Methamphetamine: Impact on Health and the Environment” |
| OCT
14, 2005 |
"Stopping
the Methamphetamine Epidemic: Lessons From the Pacific Northwest" |
| SEP
27, 2005 |
"H.R.
3889, the "Methamphetamine Epidemic Elimination Act of 2005" |
| SEP
13, 2005 |
"Status
of the Efforts of the FDA and DEA in regulating Schedule II Prescription
Painkillers, Specifically OxyContin® and Other Opioid Analgesics" |
| AUG
23, 2005 |
"Law
Enforcement and the Fight Against Methamphetamine: Improving
Federal, State and Local Efforts " |
| JUL
26, 2005 |
“Fighting
Meth in America’s Heartland: Assessing the Impact on Local
Law Enforcement and Child Welfare Agencies” |
| JUN
29, 2005 |
“Interrupting
Narco-Terrorist Threats on the High Seas: Do We Have Enough Wind
in Our Sails?” |
| JUN
27, 2005 |
“Fighting
Meth in America’s Heartland: Assessing Federal, State,
and Local Efforts” |
| JUN
14, 2005 |
Threat
Convergence Along the Border: How Does Drug Trafficking Impact
our Borders?” |
| APR
12, 2005 |
Defending
America’s Most Vulnerable: Safe Access to Drug Treatment
and Child Protection Act of 2005 -- H.R. 1528 |
| MAR
17, 2005 |
U.S.
Counternarcotics Policy in Afghanistan: Time for Leadership |
| MAR
16, 2005 |
Statement
of Karen P. Tandy, Administrator, Drug Enforcement Administration,
Before the United States House of Representatives Committee on
Appropriations Subcommittee on the Departments of Science, State,
Justice, and Commerce |
|
